Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

222
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
222
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

79
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
79

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Applying Artificial Intelligence and machine learning in precision nutrition.

Nature communications·2026
Same author

A Multi-Omics Processing Pipeline (MOPP) for Extracting Taxonomic and Functional Insights from Metaribosome Profiling (metaRibo-Seq) data.

bioRxiv : the preprint server for biology·2026
Same author

Farnesoid X receptor-dependent microbiome-bile acid signaling mediates obstructive sleep apnea-induced atherosclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Faecal microbiota transplant for chronic norovirus infection: a case report of donor microbiota engraftment without clinical success.

Gastroenterology report·2026
Same author

AI in Residency Application Reviews: Emerging Legal Risks.

JAMA·2026
Same author

A searchable metadata network graph for microbiome metabolomics.

bioRxiv : the preprint server for biology·2026

Video Experimental Relacionado

Updated: May 5, 2026

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.7K

La industria de las pruebas de microbioma DTC necesita más regulación

Diane E Hoffmann1, Erik C von Rosenvinge2,3, Mary-Claire Roghmann3,2,4

  • 1University of Maryland School of Law, Baltimore, MD, USA.

Science (New York, N.Y.)
|March 14, 2024
PubMed
Resumen

Muchas pruebas de diagnóstico carecen de validez científica, lo que indica la necesidad de una mayor supervisión federal para proteger a los consumidores de posibles daños.

Más Videos Relacionados

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
07:21

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

12.8K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

Videos de Experimentos Relacionados

Last Updated: May 5, 2026

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.7K
Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
07:21

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

12.8K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

Área de la Ciencia:

  • Diagnóstico médico
  • Ciencias de la regulación

Sus antecedentes:

  • Las pruebas de diagnóstico son cruciales para las decisiones de atención médica.
  • Garantizar la exactitud y fiabilidad de los ensayos es primordial.

Objetivo del estudio:

  • Evaluar la validez analítica y clínica de las pruebas de diagnóstico.
  • Evaluar la necesidad de una mayor supervisión reguladora federal.

Principales métodos:

  • Revisión de la literatura existente sobre la validación de las pruebas de diagnóstico.
  • Análisis de los marcos normativos que rigen las pruebas de diagnóstico.

Principales resultados:

  • Se identificaron lagunas significativas en la validez analítica y clínica de numerosas pruebas.
  • La evidencia sugiere que la supervisión actual es insuficiente para evitar daños a los consumidores.

Conclusiones:

  • Las pruebas de diagnóstico requieren una validación rigurosa para garantizar la precisión.
  • El aumento de la supervisión federal es necesario para salvaguardar la salud pública y prevenir el daño de las pruebas no válidas.